Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5507 | 0.97 | — | — | |
| Water SCHEMBL9764760 | 0.94 | — | — | |
| SCHEMBL28745257 | 0.94 | — | — | |
| SCHEMBL10666861 | 0.94 | — | — | |
| Hydrogen Sulfide SCHEMBL27518477 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL7267735 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL2911520 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL6307325 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL20767879 | 0.92 | — | — | |
| Methyl Alcohol SCHEMBL475415 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120022522-A | Drug-loaded microneedle, drug-loaded microneedle patch and electrically-controlled drug release microneedle system | 成都邦迈医创科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-107870190-B | Genetic biochemical locus marker of cerebral ischemia inbred-line meriones unguiculatus and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2020-02-07 | — | — | CN | claimed |
| US-6852495-B2 | Process of extracting nucleic acid and process of simultaneously carrying out extraction and purification of nucleic acid | SHIMADZU CORPORATION (JP) | 2005-02-08 | — | — | US | claimed |
| US-20030229222-A1 | Process of extracting nucleic acid and process of simultaneously carrying out extraction and purification of nucleic acid | SHIMADZU CORPORATION (JP) | 2003-12-11 | — | — | US | claimed |
| US-6630585-B2 | Method for purifying nucleic acids from feces | SHIMADZU CORPORATION (JP) | 2003-10-07 | — | — | US | claimed |
| US-20020068292-A1 | Method for purifying nucleic acids from feces | SHIMADZU CORPORATION | 2002-06-06 | — | — | US | claimed |
| CN-120022522-A | Drug-loaded microneedle, drug-loaded microneedle patch and electrically-controlled drug release microneedle system | 成都邦迈医创科技有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-119330823-A | Long carbon chain hydroxyl-containing branched dicarboxylic acid, and preparation method and application thereof | 华中师范大学 | 2025-01-21 | — | — | CN | disclosed |
| CN-107870190-B | Genetic biochemical locus marker of cerebral ischemia inbred-line meriones unguiculatus and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2020-02-07 | — | — | CN | disclosed |
| US-10294203-B2 | Organic compound and electronic device comprising an organic layer comprising the organic compound | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-05-21 | — | — | US | disclosed |
| CN-107870190-A | The hereditary biochemical site-tag of cerebral ischemia inbred strais meriones unguiculatus and its application | 中国人民解放军军事科学院军事医学研究院 | 2018-04-03 | — | — | CN | disclosed |
| US-20170334849-A1 | ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING AN ORGANIC LAYER COMPRISING THE ORGANIC COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-11-23 | — | — | US | disclosed |
| CN-106691902-A | Composition containing ampelopsis and acacia extract and use method of composition | 强生消费者公司 | 2017-05-24 | — | — | CN | disclosed |
| US-6852495-B2 | Process of extracting nucleic acid and process of simultaneously carrying out extraction and purification of nucleic acid | SHIMADZU CORPORATION (JP) | 2005-02-08 | — | — | US | disclosed |
| US-20030229222-A1 | Process of extracting nucleic acid and process of simultaneously carrying out extraction and purification of nucleic acid | SHIMADZU CORPORATION (JP) | 2003-12-11 | — | — | US | disclosed |
| US-RE38330-E1 | Preventing and reversing advanced glycosylation endproducts | ALTEON INC. | 2003-11-25 | — | — | US | disclosed |
| US-6630585-B2 | Method for purifying nucleic acids from feces | SHIMADZU CORPORATION (JP) | 2003-10-07 | — | — | US | disclosed |
| US-20020068292-A1 | Method for purifying nucleic acids from feces | SHIMADZU CORPORATION | 2002-06-06 | — | — | US | disclosed |
| US-6391899-B1 | STROKE THERAPY; CARDIOVASCULAR DISORDERS | North Shore—Long Island Jewish Research Institute | 2002-05-21 | — | — | US | disclosed |
| US-5011847-A | 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists | MERCK & CO., INC. (US) | 1991-04-30 | — | — | US | disclosed |